Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100368400C reveals a novel Pd-catalyzed hydrogenation route for halogenated pyridines, offering significant cost reduction in insecticide manufacturing and scalable supply chain solutions.
Discover the metal-free synthesis of E-type beta-thiocyanatelamide derivatives via patent CN112010722A. Achieve high stereoselectivity and cost efficiency in API manufacturing.
Novel patent CN1054522228A enables safer Febuxostat synthesis. Eliminate toxic cyanide. Reliable pharmaceutical intermediates supplier for cost reduction.
Novel acid-catalyzed acylcyanation of electron-rich alkynes. High selectivity, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Discover the novel synthesis of potential antiviral intermediate BL via patent CN115894498A. Offers high diastereoselectivity and scalable manufacturing for global supply chains.
Patent CN115894498A reveals a high-yield route for antiviral intermediate BL. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Patent CN112028806B reveals a novel synthetic method for Vildagliptin intermediates, achieving 99.7% purity and 80.6% yield through stabilized cyanuric chloride dehydration.
Novel electrophilic thiocyanation reagent synthesis via mild chlorination. High yield process for fine chemical manufacturing cost reduction and supply chain reliability.
Advanced synthesis of benzamide intermediates via CN104884427B. Offers superior purity and scalable routes for cardiovascular drug manufacturing.
Patent CN104031063A reveals novel cyanation route for high-purity quinolone intermediates enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN110483440A reveals a mild three-step route for high-purity thiazole intermediates. This process offers significant supply chain stability and cost optimization for pharmaceutical manufacturing.
Novel synthesis route for Topiroxostat intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing scale-up.
Novel 5-step synthesis for biaryl quinolin derivatives. High yield, purified process. Reliable pharmaceutical intermediates supplier for TB drug development.
Patent CN105985263B details copper-catalyzed route reducing toxicity. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel nickel bromide catalyzed cyanation method offers superior yield and purity for key herbicide intermediates, ensuring reliable supply chain performance.
Patent CN100338008C details a scalable synthesis of 1-carboxy-1-(3,5-dimethoxyphenyl)-2-(4-R phenyl) ethylene. Discover cost-effective routes for high-purity antitumor intermediates.
Patent CN1101819C details high-yield synthesis of antineoplastic podophyllotoxin derivatives offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN105130949A details a safer synthesis route for difluoro cyclopropyl nitrile. This method ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN115850244B reveals a green cyanation route for Topiroxostat. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN112041298A details a safe, efficient route for aromatic nitriles via Willgerodt rearrangement. Reduces sulfur impurities and avoids toxic cyanides for pharma intermediates.